# RetiSpec

its AI-driven hyperspectral eye test analyzes retinal spectral signatures associated with Alzheimer's disease, recently closing a $10 million USD funding round to advance commercialization, with the underlying imaging technology documented in a dedicated patent filing.

Source: https://en.bioecon.ru/companies/retispec/
Updated: 2026-07-20

- Country: Canada

## Technologies

- [Retinal biomarkers for neurodegenerative disease](https://en.bioecon.ru/technology/retinal-biomarkers-neurodegenerative-disease/)